Cargando…
Clinicopathologic Features of Kinase Fusion-related Thyroid Carcinomas: An Integrative Analysis with Molecular Characterization
The discovery of actionable kinase gene rearrangements has revolutionized the therapeutic landscape of thyroid carcinomas. Unsolved challenges include histopathologic recognition of targetable cases, correlation between genotypes and tumor behavior, and evolving resistance mechanisms against kinase...
Autores principales: | Chu, Ying-Hsia, Wirth, Lori J., Farahani, Alexander A., Nosé, Vânia, Faquin, William C., Dias-Santagata, Dora, Sadow, Peter M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7688509/ https://www.ncbi.nlm.nih.gov/pubmed/32737449 http://dx.doi.org/10.1038/s41379-020-0638-5 |
Ejemplares similares
-
Response to RET-Specific Therapy in RET Fusion-Positive Anaplastic Thyroid Carcinoma
por: Dias-Santagata, Dora, et al.
Publicado: (2020) -
Poorly Differentiated Thyroid Carcinoma: An Incubating Entity
por: Sadow, Peter M., et al.
Publicado: (2012) -
Clinically Integrated Molecular Diagnostics in Adenoid Cystic Carcinoma
por: Thierauf, Julia, et al.
Publicado: (2019) -
Metastasis-associated MCL1 and P16 copy number alterations dictate resistance to vemurafenib in a BRAF(V600E) patient-derived papillary thyroid carcinoma preclinical model
por: Duquette, Mark, et al.
Publicado: (2015) -
Diagnostic Value of MAML2 Rearrangements in Mucoepidermoid Carcinoma
por: Thierauf, Julia C., et al.
Publicado: (2022)